SCHEMBL19080134

SCHEMBL19080134

c1ccc(-c2cc(-c3c4ccccc4c(-c4cccc(-c5ccc6c7ccccc7c7c(oc8ccc9ccccc9c87)c6c5)c4)c4ccccc34)c3ccccc3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.37
CYP1A2 P05177 4/20 0.37
CYP1A1 P04798 3/20 0.37
AHR P35869 2/20 0.37
PAX8 Q06710 2/20 0.37
FYN P06241 1/20 0.37
MAPK3 P27361 1/20 0.37
HSD17B1 P14061 2/20 0.35
HSD17B2 P37059 2/20 0.35
PGR P06401 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
GPR84 Q9NQS5 2/20 0.33
PLA2G10 O15496 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP3A4 P08684 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079974 0.91 AHR (0.37) ABCG2CYP1A2CYP1A1AHRPAX8
SCHEMBL19079939 0.90 ABCG2 (0.42) ABCG2CYP1A2CYP1A1AHRPAX8
SCHEMBL19080118 0.89 AHR (0.37) ABCG2CYP1A2CYP1A1AHRPAX8
SCHEMBL19080005 0.89 CYP1A1 (0.40) ABCG2CYP1A2CYP1A1AHRPAX8
SCHEMBL19080136 0.87 HSD17B1 (0.35) CYP1A2HSD17B1HSD17B2PLA2G2APLA2G4A
SCHEMBL19080068 0.86 CYP1A1 (0.35) ABCG2CYP1A2CYP1A1AHRPAX8
SCHEMBL19079963 0.84 AHR (0.34) ABCG2CYP1A2CYP1A1AHRPAX8
SCHEMBL19080041 0.84 CYP1A1 (0.41) ABCG2CYP1A2CYP1A1AHRPAX8
SCHEMBL19079953 0.84 ABCG2 (0.43) ABCG2CYP1A2CYP1A1AHRPAX8
SCHEMBL20127730 0.84 ABCG2 (0.40) ABCG2CYP1A2CYP1A1AHRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ABCG2 4758/4885CYP1A2 621/4885CYP1A1 147/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ABCG2 4758/4885CYP1A2 621/4885CYP1A1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.